Zengpeng Han
Shenzhen Key Laboratory Of Viral Vectors For Biomedicine, Key Laboratory Of Quality Control Technology For Virus Based Therapeutics, NMPA Key Laboratory For Research And Evaluation Of Viral Vector Technology In Cell And Gene Therapy Medicinal Products
Shenzhen, 518055, China
Shenzhen, 518055, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9.
Journal: Pathogens (Basel, Switzerland)
Published: April 16, 2023
Computer-Aided Directed Evolution Generates Novel AAV Variants with High Transduction Efficiency.
Journal: Viruses
Published: January 31, 2023
AAV13 Enables Precise Targeting of Local Neural Populations.
Journal: International journal of molecular sciences
Published: September 27, 2022
Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes.
Journal: Current gene therapy
Published: November 06, 2020
Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
Journal: Human gene therapy methods
Published: October 01, 2019
A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae.
Journal: Molecular therapy. Methods & clinical development
Published: December 09, 2017
Functional annotation of Alzheimer's disease associated loci revealed by GWASs.
Journal: PloS one
Published: December 14, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026